We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Lung Ultrasound Could Predict Worsening in COVID-19 Patients

By HospiMedica International staff writers
Posted on 15 Dec 2020
A new method using ultrasound imaging could serve as a diagnostic tool to help physicians predict if a patient with COVID-19 will worsen.

For some, COVID-19 can result in severe pneumonia or even death, while others remain purely asymptomatic. More...
Researchers at the Policlinico San Matteo (Pavia, Italy) have developed a method using ultrasound imaging to score a patient's lung health, which is indicative of their outcome. The ability to predict when a patient might worsen can help physicians be better prepared for caring for patients.

The researchers tested the tool on 52 patients who had been admitted to San Matteo Hospital between March 15 and April 29. They administered lung ultrasounds to the patients on arrival and before discharge to get a peek into the state of their lungs. Using 14 points in the lungs, the researchers looked for abnormalities, such as pleural irregularities, and assigned each spot a score out of 3 based on its severity.

Adding up all the points, the researchers found the total lung ultrasound score was higher for those who had a worsening outcome of COVID-19, such as needing supplementary oxygen, admission to intensive care, or death. Patients with at least three spots scoring 3 or with high overall scores were more than six times more likely to have a worsening outcome than other patients.

From their results, the researchers proposed a graph called a nomogram that can help physicians compute the probability a patient will worsen based on their lung ultrasound score. The diagnostic will help physicians rapidly evaluate and predict how a patient will worsen due to COVID-19. The test is also quick to perform. A scan of each spot takes 10 seconds, making the whole exam last only 15 to 20 minutes.

Related Links:
Policlinico San Matteo


Gold Member
Blood Gas Analyzer
i-Check200
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Syringe Pump
SP50 Series
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Annotation platform for pixel-level labeling of free-text findings in 3D chest CT. (Baharoon M, Luo L, Moritz M, et al. ReXGroundingCT: A 3D chest CT dataset for segmentation of findings from free-text reports. NEJM AI. 2026;3(7). doi:10.1056/AIdbp2501220.)

Public Chest CT Dataset Supports Explainable AI in Diagnostic Radiology

Chest computed tomography scans generate complex three-dimensional images that can be difficult for artificial intelligence systems to explain clearly. Clinicians need to verify AI findings before using... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.